{"hands_on_practices": [{"introduction": "Understanding smooth muscle contraction begins at the cell membrane. The electrical potential across this membrane governs the activity of voltage-gated ion channels, a key control point for initiating contraction. This first exercise guides you through the derivation of the Goldman–Hodgkin–Katz (GHK) equation from first principles, allowing you to calculate the resting membrane potential and predict how it responds to changes in ion channel activity, a process fundamental to electromechanical coupling. [@problem_id:4929998]", "problem": "A single-unit visceral smooth muscle cell at steady state can be modeled as a thin, homogeneous membrane separating intracellular and extracellular solutions. Ionic movement arises from diffusion and the electric field across the membrane. Consider three monovalent ions, potassium ($\\mathrm{K}^{+}$), sodium ($\\mathrm{Na}^{+}$), and chloride ($\\mathrm{Cl}^{-}$), each with valence $z_{i}$ equal to $+1$ for cations and $-1$ for anions. The ionic flux density for species $i$ is governed by the Nernst–Planck equation,\n$$\nJ_{i}(x) \\;=\\; -D_{i}\\left(\\frac{dC_{i}}{dx} \\;+\\; \\frac{z_{i}F}{RT}\\,C_{i}\\,\\frac{d\\phi}{dx}\\right),\n$$\nwhere $D_{i}$ is the diffusion coefficient, $C_{i}$ is concentration, $\\phi$ is electric potential, $F$ is Faraday’s constant, $R$ is the gas constant, and $T$ is absolute temperature. Assume the constant-field approximation (the transmembrane electric field is spatially uniform), steady state (each $J_{i}$ is spatially constant), and zero net transmembrane current at rest (the sum of ionic currents is zero). Use these assumptions to derive an explicit expression for the resting membrane potential $V_{m}$ in terms of permeabilities $P_{i}$ and boundary concentrations for $\\mathrm{K}^{+}$, $\\mathrm{Na}^{+}$, and $\\mathrm{Cl}^{-}$. State clearly how $P_{i}$ arises from the Nernst–Planck formulation under the constant-field approximation.\n\nYou are then given the following physiologically plausible smooth muscle parameters at $T=310\\ \\mathrm{K}$:\n- Extracellular concentrations: $[\\mathrm{K}^{+}]_{o} = 5\\ \\mathrm{mM}$, $[\\mathrm{Na}^{+}]_{o} = 145\\ \\mathrm{mM}$, $[\\mathrm{Cl}^{-}]_{o} = 110\\ \\mathrm{mM}$.\n- Intracellular concentrations: $[\\mathrm{K}^{+}]_{i} = 140\\ \\mathrm{mM}$, $[\\mathrm{Na}^{+}]_{i} = 15\\ \\mathrm{mM}$, $[\\mathrm{Cl}^{-}]_{i} = 10\\ \\mathrm{mM}$.\n- Baseline relative permeabilities: $P_{\\mathrm{K}}:P_{\\mathrm{Na}}:P_{\\mathrm{Cl}} = 1:0.05:0.45$.\n\nA vasodilatory stimulus opens additional $\\mathrm{K}^{+}$ channels, increasing the effective $\\mathrm{K}^{+}$ permeability by a factor of $3$ while leaving $\\mathrm{Na}^{+}$ and $\\mathrm{Cl}^{-}$ permeabilities unchanged.\n\nUsing your derived expression, predict the new resting membrane potential after this change. Express your final numerical answer in millivolts and round your answer to three significant figures. For grading purposes, report only the new resting membrane potential as your final numeric answer. Do not include units inside the final answer box.", "solution": "The problem is subjected to validation.\n\n### Step 1: Extract Givens\n- **Model:** Single-unit visceral smooth muscle cell at steady state, modeled as a thin, homogeneous membrane.\n- **Ions:** Monovalent ions potassium ($\\mathrm{K}^{+}$), sodium ($\\mathrm{Na}^{+}$), and chloride ($\\mathrm{Cl}^{-}$).\n- **Valences:** $z_{i} = +1$ for cations ($\\mathrm{K}^{+}$, $\\mathrm{Na}^{+}$), $z_{i} = -1$ for anions ($\\mathrm{Cl}^{-}$).\n- **Governing Equation:** The Nernst–Planck equation for ionic flux density $J_{i}(x)$:\n  $$J_{i}(x) = -D_{i}\\left(\\frac{dC_{i}}{dx} + \\frac{z_{i}F}{RT}\\,C_{i}\\,\\frac{d\\phi}{dx}\\right)$$\n  where $D_{i}$ is the diffusion coefficient, $C_{i}$ is concentration, $\\phi$ is electric potential, $F$ is Faraday’s constant, $R$ is the gas constant, and $T$ is absolute temperature.\n- **Assumptions:**\n  1.  Constant-field approximation: The transmembrane electric field, $E = -d\\phi/dx$, is spatially uniform.\n  2.  Steady state: Each ionic flux density $J_{i}$ is spatially constant.\n  3.  Zero net transmembrane current: The sum of ionic currents, $I_i = z_i F J_i$, is zero at rest, i.e., $\\sum_i I_i = 0$.\n- **Task Part 1:** Derive an explicit expression for the resting membrane potential $V_{m}$ in terms of permeabilities $P_{i}$ and boundary concentrations. State how $P_{i}$ arises.\n- **Temperature:** $T = 310\\ \\mathrm{K}$.\n- **Extracellular Concentrations:** $[\\mathrm{K}^{+}]_{o} = 5\\ \\mathrm{mM}$, $[\\mathrm{Na}^{+}]_{o} = 145\\ \\mathrm{mM}$, $[\\mathrm{Cl}^{-}]_{o} = 110\\ \\mathrm{mM}$.\n- **Intracellular Concentrations:** $[\\mathrm{K}^{+}]_{i} = 140\\ \\mathrm{mM}$, $[\\mathrm{Na}^{+}]_{i} = 15\\ \\mathrm{mM}$, $[\\mathrm{Cl}^{-}]_{i} = 10\\ \\mathrm{mM}$.\n- **Baseline Relative Permeabilities:** $P_{\\mathrm{K}}:P_{\\mathrm{Na}}:P_{\\mathrm{Cl}} = 1:0.05:0.45$.\n- **Stimulus:** A vasodilatory stimulus increases the effective $\\mathrm{K}^{+}$ permeability by a factor of $3$. $\\mathrm{Na}^{+}$ and $\\mathrm{Cl}^{-}$ permeabilities are unchanged.\n- **Task Part 2:** Predict the new resting membrane potential after this change, rounded to three significant figures.\n\n### Step 2: Validate Using Extracted Givens\n- **Scientific Grounding:** The problem is grounded in fundamental principles of membrane biophysics. The derivation of the Goldman-Hodgkin-Katz (GHK) voltage equation from the Nernst-Planck equation using the constant-field assumption is a canonical topic in physiology and biophysics.\n- **Well-Posedness:** The problem provides all necessary equations, assumptions, and data to first derive the GHK equation and then calculate a specific numerical value. The tasks are clearly defined.\n- **Objectivity:** The problem is stated using precise, objective, and quantitative language. The provided cellular parameters are physiologically realistic for a smooth muscle cell.\n- **Conclusion:** The problem is scientifically sound, well-posed, objective, and contains no identifiable flaws.\n\n### Step 3: Verdict and Action\nThe problem is deemed **valid**. A full solution will be provided.\n\n### Solution Derivation\n\nThe derivation of the resting membrane potential, $V_m$, begins with the Nernst-Planck equation for the flux of an ionic species $i$ across a membrane of thickness $L$:\n$$J_{i} = -D_{i}\\left(\\frac{dC_{i}}{dx} + \\frac{z_{i}F}{RT}\\,C_{i}\\,\\frac{d\\phi}{dx}\\right)$$\nUnder the constant-field approximation, the electric field $E = -d\\phi/dx$ is constant. Across the membrane from inside ($x=0$) to outside ($x=L$), the potential changes linearly. We define the membrane potential as $V_m = \\phi_{in} - \\phi_{out} = \\phi(0) - \\phi(L)$. Thus, the electric field is $E = - ( \\phi(L) - \\phi(0) ) / L = (\\phi(0) - \\phi(L)) / L = V_m/L$. This implies $d\\phi/dx = -V_m/L$, which is not quite right. Conventionally, we set $\\phi(0) = V_m$ and $\\phi(L) = 0$, so $d\\phi/dx = (\\phi(L) - \\phi(0)) / L = -V_m/L$. Let's use this. The Nernst-Planck equation becomes:\n$$J_{i} = -D_{i}\\left(\\frac{dC_{i}}{dx} - \\frac{z_{i}F V_m}{RTL}\\,C_{i}\\right)$$\nThis is a first-order linear ordinary differential equation for $C_i(x)$. At steady state, $J_i$ is constant. Rearranging the equation:\n$$\\frac{dC_{i}}{dx} - \\frac{z_{i}F V_m}{RTL}\\,C_{i} = -\\frac{J_i}{D_i}$$\nThis can be solved by integrating across the membrane from $x=0$ to $x=L$. A more direct path to the GHK flux equation is to solve for $J_i$. By rearranging, we get:\n$$J_i dx = -D_i dC_i + \\frac{D_i z_i F V_m}{RTL} C_i dx$$\nSolving this ODE for $C_i(x)$ with boundary conditions $C_i(0)=C_{i,in}$ and $C_i(L)=C_{i,out}$ and then solving for the constant flux $J_i$ yields the Goldman-Hodgkin-Katz flux equation:\n$$J_{i} = -P_{i} \\frac{z_i F V_m}{RT} \\frac{C_{i,in} - C_{i,out}\\exp(-z_i F V_m / RT)}{1 - \\exp(-z_i F V_m / RT)}$$\nHere, the **permeability** $P_i$ arises from the integration and is defined as $P_i = D_i/L$. It represents the diffusion coefficient of the ion scaled by the membrane thickness.\n\nThe electric current density for species $i$ is $I_i = z_i F J_i$. The condition for the resting state is that the net current is zero: $\\sum_i I_i = 0$.\n$$I_{net} = I_K + I_{Na} + I_{Cl} = 0$$\nLet's define a dimensionless potential $\\beta = \\frac{F V_m}{RT}$. The current for each ion is:\n$I_K = -P_K \\frac{F^2 V_m}{RT} \\frac{[\\mathrm{K}]_i - [\\mathrm{K}]_o \\exp(-\\beta)}{1 - \\exp(-\\beta)}$ since $z_K = +1$.\n$I_{Na} = -P_{Na} \\frac{F^2 V_m}{RT} \\frac{[\\mathrm{Na}]_i - [\\mathrm{Na}]_o \\exp(-\\beta)}{1 - \\exp(-\\beta)}$ since $z_{Na} = +1$.\n$I_{Cl} = -P_{Cl} \\frac{(-1)^2 F^2 V_m}{RT} \\frac{[\\mathrm{Cl}]_i - [\\mathrm{Cl}]_o \\exp(\\beta)}{1 - \\exp(\\beta)}$ since $z_{Cl} = -1$.\n\nTo simplify the chloride term, we multiply its fractional part by $\\frac{-\\exp(-\\beta)}{-\\exp(-\\beta)}$:\n$$\\frac{[\\mathrm{Cl}]_i - [\\mathrm{Cl}]_o \\exp(\\beta)}{1 - \\exp(\\beta)} \\times \\frac{-\\exp(-\\beta)}{-\\exp(-\\beta)} = \\frac{-[\\mathrm{Cl}]_i \\exp(-\\beta) + [\\mathrm{Cl}]_o \\exp(\\beta)\\exp(-\\beta)}{-\\exp(-\\beta) + 1} = \\frac{[\\mathrm{Cl}]_o - [\\mathrm{Cl}]_i \\exp(-\\beta)}{1 - \\exp(-\\beta)}$$\nNow, setting $\\sum_i I_i = 0$ and assuming $V_m \\neq 0$:\n$$P_K ([\\mathrm{K}]_i - [\\mathrm{K}]_o \\exp(-\\beta)) + P_{Na} ([\\mathrm{Na}]_i - [\\mathrm{Na}]_o \\exp(-\\beta)) + P_{Cl} ([\\mathrm{Cl}]_o - [\\mathrm{Cl}]_i \\exp(-\\beta)) = 0$$\nWe group terms with and without $\\exp(-\\beta)$:\n$$P_K [\\mathrm{K}]_i + P_{Na} [\\mathrm{Na}]_i + P_{Cl} [\\mathrm{Cl}]_o = (P_K [\\mathrm{K}]_o + P_{Na} [\\mathrm{Na}]_o + P_{Cl} [\\mathrm{Cl}]_i) \\exp(-\\beta)$$\nSolving for $\\exp(-\\beta)$:\n$$\\exp(-\\beta) = \\frac{P_K [\\mathrm{K}]_i + P_{Na} [\\mathrm{Na}]_i + P_{Cl} [\\mathrm{Cl}]_o}{P_K [\\mathrm{K}]_o + P_{Na} [\\mathrm{Na}]_o + P_{Cl} [\\mathrm{Cl}]_i}$$\nTaking the natural logarithm and solving for $V_m$:\n$$-\\beta = -\\frac{F V_m}{RT} = \\ln\\left(\\frac{P_K [\\mathrm{K}]_i + P_{Na} [\\mathrm{Na}]_i + P_{Cl} [\\mathrm{Cl}]_o}{P_K [\\mathrm{K}]_o + P_{Na} [\\mathrm{Na}]_o + P_{Cl} [\\mathrm{Cl}]_i}\\right)$$\n$$V_m = \\frac{RT}{F} \\ln\\left(\\frac{P_K [\\mathrm{K}]_o + P_{Na} [\\mathrm{Na}]_o + P_{Cl} [\\mathrm{Cl}]_i}{P_K [\\mathrm{K}]_i + P_{Na} [\\mathrm{Na}]_i + P_{Cl} [\\mathrm{Cl}]_o}\\right)$$\nThis is the Goldman-Hodgkin-Katz (GHK) voltage equation, which completes the first part of the task.\n\n### Numerical Calculation\nThe problem provides relative baseline permeabilities $P_{\\mathrm{K}}:P_{\\mathrm{Na}}:P_{\\mathrm{Cl}} = 1:0.05:0.45$. We can set a reference permeability, for instance $P_K=1$, so $P_{Na}=0.05$ and $P_{Cl}=0.45$. A vasodilatory stimulus increases $P_K$ by a factor of $3$. The new permeabilities, denoted with a prime, are:\n$P'_{K} = 3 \\times P_K = 3 \\times 1 = 3$\n$P'_{Na} = P_{Na} = 0.05$\n$P'_{Cl} = P_{Cl} = 0.45$\n\nThe given concentrations are:\n$[\\mathrm{K}^{+}]_{o} = 5\\ \\mathrm{mM}$, $[\\mathrm{Na}^{+}]_{o} = 145\\ \\mathrm{mM}$, $[\\mathrm{Cl}^{-}]_{o} = 110\\ \\mathrm{mM}$\n$[\\mathrm{K}^{+}]_{i} = 140\\ \\mathrm{mM}$, $[\\mathrm{Na}^{+}]_{i} = 15\\ \\mathrm{mM}$, $[\\mathrm{Cl}^{-}]_{i} = 10\\ \\mathrm{mM}$\n\nWe substitute these values into the GHK equation. Let's calculate the numerator and the denominator of the argument of the logarithm. Let the argument be $A = N/D$.\nNumerator:\n$N = P'_K [\\mathrm{K}]_o + P'_{Na} [\\mathrm{Na}]_o + P'_{Cl} [\\mathrm{Cl}]_i$\n$N = (3)(5) + (0.05)(145) + (0.45)(10) = 15 + 7.25 + 4.5 = 26.75$\n\nDenominator:\n$D = P'_K [\\mathrm{K}]_i + P'_{Na} [\\mathrm{Na}]_i + P'_{Cl} [\\mathrm{Cl}]_o$\n$D = (3)(140) + (0.05)(15) + (0.45)(110) = 420 + 0.75 + 49.5 = 470.25$\n\nThe argument of the logarithm is $A = \\frac{26.75}{470.25} \\approx 0.056885$.\n\nNow we calculate the pre-factor $\\frac{RT}{F}$. The problem requires the final answer in millivolts ($mV$).\n$R \\approx 8.314\\ \\mathrm{J} \\cdot \\mathrm{mol}^{-1} \\cdot \\mathrm{K}^{-1}$\n$T = 310\\ \\mathrm{K}$\n$F \\approx 96485\\ \\mathrm{C} \\cdot \\mathrm{mol}^{-1}$\n$\\frac{RT}{F} = \\frac{(8.314\\ \\mathrm{J} \\cdot \\mathrm{mol}^{-1} \\cdot \\mathrm{K}^{-1}) (310\\ \\mathrm{K})}{96485\\ \\mathrm{C} \\cdot \\mathrm{mol}^{-1}} \\approx 0.02671\\ \\mathrm{V} = 26.71\\ \\mathrm{mV}$\n\nThe new resting membrane potential $V'_m$ is:\n$V'_m = \\left(\\frac{RT}{F}\\right) \\ln(A) = (26.71\\ \\mathrm{mV}) \\times \\ln\\left(\\frac{26.75}{470.25}\\right)$\n$V'_m \\approx (26.71\\ \\mathrm{mV}) \\times \\ln(0.056885)$\n$V'_m \\approx (26.71\\ \\mathrm{mV}) \\times (-2.86675)$\n$V'_m \\approx -76.575\\ \\mathrm{mV}$\n\nRounding the result to three significant figures, we get:\n$V'_m = -76.6\\ \\mathrm{mV}$", "answer": "$$\\boxed{-76.6}$$", "id": "4929998"}, {"introduction": "Once a stimulus causes intracellular calcium levels to rise, the signal must be transduced into mechanical force. This happens through the phosphorylation of myosin regulatory light chains (RLC), a process that is not instantaneous. This practice challenges you to model the dynamic, time-dependent nature of this core biochemical switch, moving beyond steady-state assumptions to see how the contractile machinery actually ramps up over time in response to a calcium signal. [@problem_id:4929962]", "problem": "A smooth muscle cell regulates contraction through reversible phosphorylation of the myosin regulatory light chain (RLC) by Myosin Light Chain Kinase (MLCK) and dephosphorylation by Myosin Light Chain Phosphatase (MLCP). Consider a uniform population of RLC sites with total fraction normalized to $1$. Let $p(t)$ denote the fraction of phosphorylated RLC at time $t$. Assume elementary mass-action kinetics for the two opposing enzyme-catalyzed steps:\n- phosphorylation is catalyzed by active MLCK and is proportional to the unphosphorylated fraction $1 - p(t)$,\n- dephosphorylation is catalyzed by MLCP and is proportional to the phosphorylated fraction $p(t)$.\n\nThe effective bimolecular rate constants for the elementary steps are:\n- MLCK-catalyzed phosphorylation: $k_{1} = 3.0 \\ \\mathrm{s}^{-1} \\ \\mu \\mathrm{M}^{-1}$,\n- MLCP-catalyzed dephosphorylation: $k_{2} = 1.0 \\ \\mathrm{s}^{-1} \\ \\mu \\mathrm{M}^{-1}$.\n\nTotal MLCK concentration is $[\\mathrm{MLCK}]_{\\mathrm{tot}} = 0.5 \\ \\mu \\mathrm{M}$. Only the fraction of MLCK bound to calcium-calmodulin (CaM) is catalytically active. The fraction of active MLCK is modeled by a Hill function of cytosolic free calcium concentration $[\\mathrm{Ca}^{2+}]$:\n$$\nf_{\\mathrm{act}}([\\mathrm{Ca}^{2+}]) = \\frac{[\\mathrm{Ca}^{2+}]^{n}}{K_{\\mathrm{Ca}}^{n} + [\\mathrm{Ca}^{2+}]^{n}},\n$$\nwith Hill coefficient $n = 2$ and half-activation constant $K_{\\mathrm{Ca}} = 0.5 \\ \\mu \\mathrm{M}$. The MLCP concentration is constant and calcium independent: $[\\mathrm{MLCP}] = 0.1 \\ \\mu \\mathrm{M}$.\n\nInitially, for $t < 0$, the cell is at steady state at a basal calcium level $[\\mathrm{Ca}^{2+}]_{\\mathrm{basal}} = 0.05 \\ \\mu \\mathrm{M}$. At $t = 0$, $[\\mathrm{Ca}^{2+}]$ steps instantly to $[\\mathrm{Ca}^{2+}]_{\\mathrm{high}} = 1.0 \\ \\mu \\mathrm{M}$ and remains constant thereafter.\n\nUsing only the above assumptions and parameters, derive from first principles the ordinary differential equation governing $p(t)$ before and after the calcium step, determine the pre-step steady-state $p(0^{-})$, and then compute the phosphorylated fraction at $t = 2.0 \\ \\mathrm{s}$ after the step, $p(2.0 \\ \\mathrm{s})$. Express your final answer as a unitless decimal fraction and round your answer to four significant figures.", "solution": "The problem is first validated against the specified criteria.\n\n### Problem Validation\n\n**Step 1: Extract Givens**\n- The fraction of phosphorylated RLC at time $t$ is denoted by $p(t)$.\n- The total fraction of RLC sites is normalized to $1$.\n- The unphosphorylated fraction is $1 - p(t)$.\n- Phosphorylation rate is proportional to $1 - p(t)$.\n- Dephosphorylation rate is proportional to $p(t)$.\n- MLCK-catalyzed phosphorylation rate constant: $k_{1} = 3.0 \\ \\mathrm{s}^{-1} \\ \\mu \\mathrm{M}^{-1}$.\n- MLCP-catalyzed dephosphorylation rate constant: $k_{2} = 1.0 \\ \\mathrm{s}^{-1} \\ \\mu \\mathrm{M}^{-1}$.\n- Total MLCK concentration: $[\\mathrm{MLCK}]_{\\mathrm{tot}} = 0.5 \\ \\mu \\mathrm{M}$.\n- Fraction of active MLCK is given by the Hill function: $f_{\\mathrm{act}}([\\mathrm{Ca}^{2+}]) = \\frac{[\\mathrm{Ca}^{2+}]^{n}}{K_{\\mathrm{Ca}}^{n} + [\\mathrm{Ca}^{2+}]^{n}}$.\n- Hill coefficient: $n = 2$.\n- Half-activation constant for MLCK: $K_{\\mathrm{Ca}} = 0.5 \\ \\mu \\mathrm{M}$.\n- MLCP concentration (constant and calcium independent): $[\\mathrm{MLCP}] = 0.1 \\ \\mu \\mathrm{M}$.\n- Initial condition for $t < 0$: steady state at $[\\mathrm{Ca}^{2+}]_{\\mathrm{basal}} = 0.05 \\ \\mu \\mathrm{M}$.\n- Condition for $t \\ge 0$: $[\\mathrm{Ca}^{2+}]$ steps instantly to $[\\mathrm{Ca}^{2+}]_{\\mathrm{high}} = 1.0 \\ \\mu \\mathrm{M}$.\n- The objective is to compute $p(t=2.0 \\ \\mathrm{s})$ and round to four significant figures.\n\n**Step 2: Validate Using Extracted Givens**\nThe problem is a standard exercise in biochemical kinetics, specifically modeling enzyme-catalyzed phosphorylation-dephosphorylation cycles.\n- **Scientifically Grounded:** The model uses mass-action kinetics and the Hill equation for allosteric regulation, which are fundamental and well-established principles in biochemistry and systems biology. The biological context (smooth muscle contraction regulation) is accurately represented by this type of model.\n- **Well-Posed:** The problem provides a first-order ordinary differential equation with a defined initial condition arising from a prior steady state. The parameters are all specified, and the question asks for the state of the system at a specific time. This structure ensures a unique and meaningful solution exists.\n- **Objective:** The problem is stated using precise, quantitative language and established scientific terminology.\n- **Consistency and Completeness:** The problem is self-contained. All necessary constants and conditions are provided to derive the governing equation and solve for the requested value. There are no contradictions in the provided data.\n- **Plausibility:** The given concentrations and rate constants are within physiologically plausible ranges for cellular signaling pathways.\n\n**Step 3: Verdict and Action**\nThe problem is scientifically valid, well-posed, and internally consistent. The solution process may proceed.\n\n### Derivation and Solution\n\nThe rate of change of the phosphorylated RLC fraction, $\\frac{dp}{dt}$, is the difference between the rate of phosphorylation and the rate of dephosphorylation.\n\nBased on the law of mass action for the enzyme-catalyzed steps, the rates are:\n- Rate of phosphorylation = $k_{1} [\\text{active MLCK}] (1 - p(t))$.\n- Rate of dephosphorylation = $k_{2} [\\mathrm{MLCP}] p(t)$.\n\nThe concentration of active MLCK is dependent on the cytosolic calcium concentration, $[\\mathrm{Ca}^{2+}]$, through the Hill function:\n$[\\text{active MLCK}] = [\\mathrm{MLCK}]_{\\mathrm{tot}} \\times f_{\\mathrm{act}}([\\mathrm{Ca}^{2+}])$.\n\nThus, the ordinary differential equation (ODE) governing $p(t)$ is:\n$$\n\\frac{dp}{dt} = k_{1} [\\mathrm{MLCK}]_{\\mathrm{tot}} f_{\\mathrm{act}}([\\mathrm{Ca}^{2+}]) (1 - p(t)) - k_{2} [\\mathrm{MLCP}] p(t)\n$$\nThis ODE can be written in a more compact form:\n$$\n\\frac{dp}{dt} = k_{\\mathrm{phos}}([\\mathrm{Ca}^{2+}])(1-p) - k_{\\mathrm{dephos}}p\n$$\nwhere $k_{\\mathrm{phos}}([\\mathrm{Ca}^{2+}])$ is the pseudo-first-order rate constant for phosphorylation, and $k_{\\mathrm{dephos}}$ is the pseudo-first-order rate constant for dephosphorylation.\n\nFirst, we calculate the constant dephosphorylation rate constant, $k_{\\mathrm{dephos}}$:\n$$\nk_{\\mathrm{dephos}} = k_{2} [\\mathrm{MLCP}] = (1.0 \\ \\mathrm{s}^{-1} \\ \\mu \\mathrm{M}^{-1}) (0.1 \\ \\mu \\mathrm{M}) = 0.1 \\ \\mathrm{s}^{-1}\n$$\n\nNext, we determine the initial condition $p(0^{-})$, which is the steady-state phosphorylated fraction at the basal calcium level $[\\mathrm{Ca}^{2+}]_{\\mathrm{basal}} = 0.05 \\ \\mu \\mathrm{M}$.\nAt steady state, $\\frac{dp}{dt} = 0$. We first calculate the phosphorylation rate constant at this calcium level, $k_{\\mathrm{phos, basal}}$.\nThe fraction of active MLCK is:\n$$\nf_{\\mathrm{act, basal}} = \\frac{[\\mathrm{Ca}^{2+}]_{\\mathrm{basal}}^{n}}{K_{\\mathrm{Ca}}^{n} + [\\mathrm{Ca}^{2+}]_{\\mathrm{basal}}^{n}} = \\frac{(0.05)^{2}}{(0.5)^{2} + (0.05)^{2}} = \\frac{0.0025}{0.25 + 0.0025} = \\frac{0.0025}{0.2525} = \\frac{1}{101}\n$$\nNow, we find $k_{\\mathrm{phos, basal}}$:\n$$\nk_{\\mathrm{phos, basal}} = k_{1} [\\mathrm{MLCK}]_{\\mathrm{tot}} f_{\\mathrm{act, basal}} = (3.0 \\ \\mathrm{s}^{-1} \\ \\mu \\mathrm{M}^{-1}) (0.5 \\ \\mu \\mathrm{M}) \\left(\\frac{1}{101}\\right) = \\frac{1.5}{101} \\ \\mathrm{s}^{-1}\n$$\nAt steady-state, $p_{ss} = \\frac{k_{\\mathrm{phos}}}{k_{\\mathrm{phos}} + k_{\\mathrm{dephos}}}$. The initial condition is:\n$$\np(0^{-}) = p_{\\mathrm{ss, basal}} = \\frac{\\frac{1.5}{101}}{\\frac{1.5}{101} + 0.1} = \\frac{1.5}{1.5 + 101 \\times 0.1} = \\frac{1.5}{1.5 + 10.1} = \\frac{1.5}{11.6} = \\frac{15}{116}\n$$\n\nFor $t \\ge 0$, the calcium concentration is stepped to $[\\mathrm{Ca}^{2+}]_{\\mathrm{high}} = 1.0 \\ \\mu \\mathrm{M}$. We must calculate the new phosphorylation rate constant, $k_{\\mathrm{phos, high}}$.\nThe new fraction of active MLCK is:\n$$\nf_{\\mathrm{act, high}} = \\frac{[\\mathrm{Ca}^{2+}]_{\\mathrm{high}}^{n}}{K_{\\mathrm{Ca}}^{n} + [\\mathrm{Ca}^{2+}]_{\\mathrm{high}}^{n}} = \\frac{(1.0)^{2}}{(0.5)^{2} + (1.0)^{2}} = \\frac{1}{0.25 + 1} = \\frac{1}{1.25} = 0.8\n$$\nThe new phosphorylation rate constant is:\n$$\nk_{\\mathrm{phos, high}} = k_{1} [\\mathrm{MLCK}]_{\\mathrm{tot}} f_{\\mathrm{act, high}} = (3.0 \\ \\mathrm{s}^{-1} \\ \\mu \\mathrm{M}^{-1}) (0.5 \\ \\mu \\mathrm{M}) (0.8) = 1.2 \\ \\mathrm{s}^{-1}\n$$\nThe ODE for $t \\ge 0$ is:\n$$\n\\frac{dp}{dt} = 1.2(1-p) - 0.1p = 1.2 - 1.2p - 0.1p = 1.2 - 1.3p\n$$\nThis is a first-order linear ODE of the form $\\frac{dp}{dt} + a p = b$, with $a = 1.3 \\ \\mathrm{s}^{-1}$ and $b = 1.2 \\ \\mathrm{s}^{-1}$. The general solution is $p(t) = p_{\\mathrm{ss, high}} + (p(0) - p_{\\mathrm{ss, high}}) \\exp(-at)$, where $p(0) = p(0^{-})$ is the initial condition and $p_{\\mathrm{ss, high}}$ is the new steady-state fraction as $t \\to \\infty$.\n\nThe new steady-state fraction is:\n$$\np_{\\mathrm{ss, high}} = \\frac{k_{\\mathrm{phos, high}}}{k_{\\mathrm{phos, high}} + k_{\\mathrm{dephos}}} = \\frac{1.2}{1.2 + 0.1} = \\frac{1.2}{1.3} = \\frac{12}{13}\n$$\nThe solution for $p(t)$ for $t \\ge 0$ is:\n$$\np(t) = \\frac{12}{13} + \\left(\\frac{15}{116} - \\frac{12}{13}\\right) \\exp(-1.3 t)\n$$\nWe need to compute the value of $p(t)$ at $t = 2.0 \\ \\mathrm{s}$:\n$$\np(2.0) = \\frac{12}{13} + \\left(\\frac{15}{116} - \\frac{12}{13}\\right) \\exp(-1.3 \\times 2.0)\n$$\n$$\np(2.0) = \\frac{12}{13} + \\left(\\frac{15}{116} - \\frac{12}{13}\\right) \\exp(-2.6)\n$$\nNow, we evaluate this expression numerically.\n$$\n\\frac{12}{13} \\approx 0.9230769\n$$\n$$\n\\frac{15}{116} \\approx 0.1293103\n$$\n$$\n\\exp(-2.6) \\approx 0.0742736\n$$\n$$\np(2.0) \\approx 0.9230769 + (0.1293103 - 0.9230769) \\times 0.0742736\n$$\n$$\np(2.0) \\approx 0.9230769 + (-0.7937666) \\times 0.0742736\n$$\n$$\np(2.0) \\approx 0.9230769 - 0.0589636\n$$\n$$\np(2.0) \\approx 0.8641133\n$$\nRounding the result to four significant figures gives $0.8641$.", "answer": "$$\n\\boxed{0.8641}\n$$", "id": "4929962"}, {"introduction": "In a living organism, smooth muscle cells are regulated by a complex network of signaling pathways that do more than just raise calcium. This final exercise simulates a realistic pharmacological scenario, exploring the concept of 'calcium sensitization,' where force is modulated independently of the calcium concentration. By analyzing the interplay between a calcium-elevating signal and a pathway that alters myosin phosphatase activity, you will learn to predict the net effect of sophisticated regulatory inputs on muscle tone. [@problem_id:4930110]", "problem": "An isolated ring of vascular smooth muscle from a small artery is mounted in an organ bath at $37\\,^\\circ\\text{C}$ and equilibrated in physiological saline solution under a preload that gives low basal tone. After stabilization, the tissue is exposed to a selective muscarinic acetylcholine receptor subtype $3$ ($M_3$) agonist at $1\\,\\mu\\text{M}$ and, simultaneously, to a Rho-associated coiled-coil containing protein kinase (ROCK) inhibitor at a concentration titrated previously to suppress $\\ge 80\\%$ of ROCK activity. Predict the net steady-state change in active force relative to baseline and relative to $M_3$ agonist alone, and choose the best option below. Your justification should be based on first principles of smooth muscle contraction: cross-bridge cycling requires phosphorylation of the $20\\,\\text{kDa}$ myosin regulatory light chain by myosin light chain kinase (MLCK) in proportion to cytosolic free calcium concentration $[\\text{Ca}^{2+}]$, and relaxation follows dephosphorylation by myosin light chain phosphatase (MLCP). Consider how $M_3$ receptor signaling and ROCK activity modulate these processes through well-established pathways, including but not limited to phospholipase C (PLC), inositol $1,4,5$-trisphosphate ($\\text{IP}_3$), diacylglycerol (DAG), protein kinase C (PKC), and MLCP regulatory subunits.\n\nWhich outcome is most consistent with these mechanisms?\n\nA. A strong contraction comparable to $M_3$ agonist alone, because $[\\text{Ca}^{2+}]$ elevates MLCK activity and ROCK inhibition does not affect force.\n\nB. A contraction that is clearly smaller than with $M_3$ agonist alone but still above baseline, because $[\\text{Ca}^{2+}]$-dependent MLCK activation is intact while ROCK-dependent calcium sensitization via MLCP inhibition is reduced.\n\nC. A net relaxation below baseline, because ROCK inhibition removes all phosphorylation of myosin light chains despite $M_3$-induced $[\\text{Ca}^{2+}]$ elevation.\n\nD. No measurable change in force relative to $M_3$ agonist alone, because $M_3$ signaling and ROCK act on distinct molecular targets with no convergence on myosin regulation.\n\nE. An initial brief contraction followed by relaxation to baseline, because $M_3$ depletes sarcoplasmic reticulum calcium stores and ROCK inhibition prevents any sustained tone.", "solution": "To predict the net effect, begin from the core regulatory scheme for smooth muscle cross-bridge cycling. Active force depends on the fraction of cycling myosin heads, which is controlled by phosphorylation of the $20\\,\\text{kDa}$ myosin regulatory light chain ($\\text{MLC}_{20}$). Phosphorylation of $\\text{MLC}_{20}$ is catalyzed by myosin light chain kinase (MLCK), whose activity increases with cytosolic free calcium concentration $[\\text{Ca}^{2+}]$ via calcium-calmodulin binding. Dephosphorylation is catalyzed by myosin light chain phosphatase (MLCP). Thus, for a given time, the steady-state fraction of phosphorylated $\\text{MLC}_{20}$ (and hence force, $F$) reflects the balance between MLCK-mediated phosphorylation (which scales with $[\\text{Ca}^{2+}]$) and MLCP-mediated dephosphorylation (which can be modulated by signaling pathways independent of $[\\text{Ca}^{2+}]$).\n\nMuscarinic acetylcholine receptor subtype $3$ ($M_3$) couples predominantly to $G_q$, activating phospholipase C (PLC). PLC generates inositol $1,4,5$-trisphosphate ($\\text{IP}_3$) and diacylglycerol (DAG). $\\text{IP}_3$ opens $\\text{IP}_3$ receptors on the sarcoplasmic reticulum, raising $[\\text{Ca}^{2+}]$ and thereby increasing MLCK activity. DAG activates protein kinase C (PKC), which can phosphorylate CPI-17, an inhibitory protein that suppresses MLCP, thereby producing calcium sensitization (an increase in force at a given $[\\text{Ca}^{2+}]$). Independently, the small GTPase RhoA and Rho-associated coiled-coil containing protein kinase (ROCK) increase calcium sensitization by phosphorylating the MLCP regulatory subunit MYPT1, decreasing MLCP activity. Therefore, with $M_3$ agonist alone, two sets of processes increase force: (i) elevated $[\\text{Ca}^{2+}]$ activates MLCK, and (ii) MLCP is inhibited via PKC/CPI-17 and ROCK/MYPT1, both increasing the fraction of phosphorylated $\\text{MLC}_{20}$.\n\nWhen a ROCK inhibitor suppresses $\\ge 80\\%$ of ROCK activity, the ROCK-mediated inhibition of MLCP via MYPT1 phosphorylation is markedly reduced. That increases MLCP activity, lowering calcium sensitization. However, the $M_3$-induced rise in $[\\text{Ca}^{2+}]$ and MLCK activation persists, and PKC-mediated MLCP inhibition via CPI-17 may still operate because ROCK inhibition does not block PKC directly. Consequently, the co-application produces a steady-state with less $\\text{MLC}_{20}$ phosphorylation than $M_3$ agonist alone (because MLCP is less inhibited), but more than baseline (because $[\\text{Ca}^{2+}]$ is elevated and MLCK remains active). Thin filament regulatory effects (e.g., PKC-mediated modulation of caldesmon and calponin) can also contribute to sustained tone under $M_3$ stimulation, and these are not abolished by ROCK inhibition. Therefore, the net force is expected to be reduced compared with $M_3$ alone, yet still increased above baseline.\n\nEvaluate each option:\n\nA. A strong contraction comparable to $M_3$ agonist alone, because $[\\text{Ca}^{2+}]$ elevates MLCK activity and ROCK inhibition does not affect force. Verdict: Incorrect. ROCK inhibition affects calcium sensitization by disinhibiting MLCP; the fraction of phosphorylated $\\text{MLC}_{20}$ and thus force would decrease relative to $M_3$ alone.\n\nB. A contraction that is clearly smaller than with $M_3$ agonist alone but still above baseline, because $[\\text{Ca}^{2+}]$-dependent MLCK activation is intact while ROCK-dependent calcium sensitization via MLCP inhibition is reduced. Verdict: Correct. This integrates the continued MLCK activation from elevated $[\\text{Ca}^{2+}]$ with diminished MLCP inhibition when ROCK is blocked, yielding reduced sensitization and a force between baseline and $M_3$-alone.\n\nC. A net relaxation below baseline, because ROCK inhibition removes all phosphorylation of myosin light chains despite $M_3$-induced $[\\text{Ca}^{2+}]$ elevation. Verdict: Incorrect. ROCK inhibition does not remove MLCK-mediated phosphorylation; $[\\text{Ca}^{2+}]$ elevation by $M_3$ persists, so force should not drop below baseline.\n\nD. No measurable change in force relative to $M_3$ agonist alone, because $M_3$ signaling and ROCK act on distinct molecular targets with no convergence on myosin regulation. Verdict: Incorrect. Both pathways converge on MLCP/MLCK balance and thereby on $\\text{MLC}_{20}$ phosphorylation; ROCK inhibition reduces calcium sensitization.\n\nE. An initial brief contraction followed by relaxation to baseline, because $M_3$ depletes sarcoplasmic reticulum calcium stores and ROCK inhibition prevents any sustained tone. Verdict: Incorrect. Although $\\text{IP}_3$-mediated release can be transient, sustained $M_3$ stimulation typically maintains tone through receptor-operated and store-operated calcium entry and PKC-mediated mechanisms; ROCK inhibition reduces sensitization but does not abolish all sustained pathways.\n\nTherefore, the best prediction is a reduced contraction relative to $M_3$ alone, still above baseline.", "answer": "$$\\boxed{B}$$", "id": "4930110"}]}